Pathogenesis of endothelial cell dysfunction in chronic kidney disease: A retrospective and what the future may hold

Kidney Research and Clinical Practice

Volumn 34, Issue 2, 2015, Pages 76-82

  Goligorsky, Michael S ^a  

^a RENAL RESEARCH INSTITUTE   (United States)

Author keywords

Endothelial to mesenchymal transition; Metabolomics; Premature senescence proteomics; Stress induced

Indexed keywords

ANTIOXIDANT; BARDOXOLONE METHYL; ENDOSTATIN; GLUTAMINE; HOMOCYSTEINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; KELCH LIKE ECH ASSOCIATED PROTEIN 1; MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA AGONIST; RESVERATROL; SIRTUIN; STRESS ACTIVATED PROTEIN KINASE; THIOCTIC ACID; TRANSCRIPTION FACTOR NRF2; TRANSFORMING GROWTH FACTOR BETA;

CELL AGING; CHRONIC KIDNEY DISEASE; ENDOTHELIAL CELL DYSFUNCTION; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; GENETIC ANALYSIS; GENETIC ASSOCIATION; HUMAN; LASER DOPPLER FLOWMETRY; METABOLOMICS; MOLECULAR PATHOLOGY; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEOMICS; REVIEW; SCREENING TEST; SIGNAL TRANSDUCTION; SYMPTOM ASSESSMENT;

EID: 84937522335     PISSN: 22119132     EISSN: 22119140     Source Type: Journal    
DOI: 10.1016/j.krcp.2015.05.003     Document Type: Review

References (34)

1. J Catravas, J Lazo, K Dobuler, LR Mills, and CN Gillis Pulmonary endothelial dysfunction in the presence or absence of interstitial injury induced by intratracheally injected bleomycin in rabbits Am Rev Respir Dis 128 1983 740 746
2. P Ludmer, A Selwyn, T Shook, RR Wayne, GH Mudge, RW Alexander, and P Ganz Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries N Engl J Med 315 1986 1046 1051
3. MS Goligorsky Regenerative Nephrology 2010 Elsevier Amsterdam 275 287
4. MS Goligorsky Clinical assessment of endothelial dysfunction: combine and rule Curr Opin Nephrol Hypertens 15 2006 617 624
5. IV Smirnova, T Sawamura, and MS Goligorsky Upregulation of lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) in endothelial cells by nitric oxide deficiency Am J Physiol Renal Physiol 287 2004 F25 F32
6. H Li, A Lewis, S Brodsky, R Rieger, C Iden, and MS Goligorsky Homocysteine induces 3-hydroxy-3-methylglutaryl coenzyme a reductase in vascular endothelial cells: a mechanism for development of atherosclerosis? Circulation 105 2002 1037 1043
7. H Li, S Brodsky, S Kumari, V Valiunas, P Brink, J Kaide, A Nasjletti, and MS. Goligorsky Paradoxical overexpression and translocation of connexin-43 in homocysteine-treated endothelial cells Am J Physiol Heart 282 2002 H2124 H2133
8. E O'Riordan, N Mendelev, S Patschan, P Chander, and MS Goligorsky Chronic NOS inhibition actuates endothelial - mesenchymal transformation Am J Physiol 292 2007 H285 H294
9. EM Zeisberg, SE Potenta, H Sugimoto, M Zeisberg, and R Kalluri Fibroblasts in kidney fibrosis emerge via endothelial-to-mesenchymal transition J Am Soc Nephrol 19 2008 2282 2287
10. J Li, X Qu, and JF Berthram Endothelial-myofibroblast transition contributes to the early development of diabetic renal interstitial fibrosis in streptozotocin-induced diabetic mice Am J Pathol 175 2009 1380 1388
11. MS Goligorsky Endothelial cell dysfunction: can't live with it, how to live without it Am J Physiol Renal Physiol 288 2005 F871 F880
12. H Li, and MS Goligorsky Endothelial gene responses to homocysteine: relation to atherosclerosis Nephron Exp Nephrol 10 2002 164 169
13. F Addabbo, B Ratliff, HC Park, MC Kuo, Z Ungvari, A Csiszar, B Krasnikov, K Sodhi, F Zhang, A Nasjletti, and MS Goligorsky The Krebs cycle and mitochondrial mass are early victims of endothelial dysfunction Am J Pathol 174 2009 34 43
14. A Stoessel, A Paliege, F Theilig, F Addabbo, B Ratliff, J Waschke, D Patschan, MS Goligorsky, and S Bachmann Indolent course of tubulointerstitial disease in a mouse model of subpressor, low-dose nitric oxide synthase inhibition Am J Physiol Renal Physiol 295 2008 F717 F725
15. F Addabbo, Q Chen, DP Patel, M Rabadi, B Ratliff, F Zhang, JF Jasmin, M Wolin, M Lisanti, SS Gross, and MS. Goligorsky Glutamine supplementation alleviates vasculopathy and alters plasma metabolome in an in vivo model of endothelial cell dysfunction PLoS One 8 2013 e65458
16. A Melk, and P Halloran Cell senescence and its implications for Nephrology J Am Soc Nephrol 12 2001 385 393
17. J Chen, SV Brodsky, DM Goligorsky, DJ Hampel, H Li, SS Gross, and MS Goligorsky Glycated collagen I induces premature senescence-like phenotypic changes in endothelial cells Circ Res 90 2002 1290 1298
18. SV Brodsky, O Gealekman, J Chen, F Zhang, N Togashi, M Crabtree, SS Gross, A Nasjletti, and MS Goligorsky Prevention and reversal of premature endothelial cell senescence and vasculopathy in obesity-induced diabetes by ebselen Circ Res 94 2004 377 384
19. J Chen, and MS Goligorsky Premature senescence of endothelial cells: Methusaleh's dilemma Am J Physiol Heart Circ Physiol 290 2006 H1729 H1739
20. MS Goligorsky, J Chen, and S Patschan Stress-induced premature senescence of endothelial cells: a perilous state between recovery and point of no return Curr Opin Hematol 16 2009 215 219
21. T Tchkonia, Y Zhu, J van Deursen, J Campisi, and J Kirkland Cellular senescence and the senescent secretory phenotype: therapeutic opportunities J Clin Invest 123 2013 966 972
22. K Hemmen, T Reinl, K Buttler, F Behler, H Dieken, L Jänsch, J Wilting, and HA Weich High-resolution mass spectrometric analysis of the secretome from mouse lung endothelial progenitor cells Angiogenesis 14 2011 163 172
23. G Pula, U Mayr, C Evans, M Prokopi, DS Vara, X Yin, Z Astroulakis, Q Xiao, J Hill, Q Xu, and M Mayr Proteomics identifies thymidine phosphorylase as a key regulator of the angiogenic potential of colony-forming units and endothelial progenitor cell cultures Circ Res 104 2009 32 40
24. N Pottier, C Cauffiez, M Perrais, P Barby, and B Mari FibromiRs: translating molecular discoveries into new anti-fibrotic drugs Trends Pharmacol Sci 35 2014 119 126
25. J Stewart, A Kohen, D Brouder, F Rahim, S Adler, R Garrick, and MS Goligorsky Non-invasive interrogation of microvasculature for signs of endothelial dysfunction in patients with chronic renal failure Am J Physiol: Heart 287 2004 H2687 H2696
26. A Kruger, J Stewart, R Sahityani, E O'Riordan, C Thompson, S Adler, R Garrick, P Vallance, and MS Goligorsky Laser Doppler flowmetry detection of endothelial dysfunction in end-stage renal disease patients: correlation with cardiovascular risk Kidney Int 70 2006 157 164
27. K Gaengel, G Genove, A Armulik, and C Betsholtz Endothelial - mural cell signaling in vascular development and angiogenesis Arterioscler Thromb Vasc Biol 29 2009 630 638
28. J Turner, C Bauer, M Abramowitz, M Melamed, and T Hostetter Treatment of chronic kidney disease Kidney Int 81 2012 351 362
29. T Miyata, N Suzuki, and C van Ypersele de Strihou Diabetic nephropathy: are there new and potentially promising therapies targeting oxygen biology? Kidney Int 84 2013 693 702
30. P Pergola, P Rasin, R Toto, C Meyer, J Huff, E Grossman, M Krauth, S Ruiz, P Audhya, H Christ-Schmidt, J Wittes, and D Warnock Bardoxolone methyl and kidney function in CKD with type 2 diabetes N Engl J Med 365 2011 327 336
31. D De Zeeuw, T Akizawa, P Audhya, GL Bakris, M Chin, H Christ-Schmidt, A Goldsberry, M Houser, M Krauth, HJ Lambers Heerspink, JJ McMurray, CJ Meyer, HH Parving, G Remuzzi, RD Toto, ND Vaziri, C Wanner, J Wittes, D Wrolstad, GM Chertow BEACON Trial Investigators Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease N Engl J Med 369 2013 2492 2503
32. E Mervaala, P Finckenberg, R Lapatto, DN Müller, JK Park, R Dechend, D Ganten, H Vapaatalo, and FC Luft Lipoic acid supplementation prevents angiotensin II-induced renal injury Kidney Int 64 2003 501 508
33. J Himmelfarb, TA Ikizler, C Ellis, P Wu, A Shintani, S Dalal, M Kaplan, M Chonchol, and RM. Hakim Provision of antioxidant therapy in hemodialysis (PATH): a randomized clinical trial J Am Soc Nephrol 25 2014 623 633
34. E Schultz, J Dopheide, S Schuhmacher, SR Thomas, K Chen, A Daiber, P Wenzel, T Münzel, and JF Keaney Jr Suppression of the JNK pathway by induction of a metabolic stress response prevents vascular injury and dysfunction Circulation 118 2008 1347 1357